Cargando…

Leflunomide-Induced Immune-Mediated Necrotizing Myopathy in a Patient With Rheumatoid Arthritis: A Case Report

Immune-mediated necrotizing myopathy (IMNM) is a subtype of inflammatory myopathy that is characterized by proximal muscle weakness, markedly elevated serum creatine kinase, myopathic electromyographic findings, and muscle biopsies revealing necrosis or regeneration with sparse inflammatory infiltra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salazar, Dylan Matthew, Damani, Devanshi Narendra, Kositangool, Piya, Ortiz, Melina Jo, Lavezo, Jonathan, Dihowm, Fatma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871974/ https://www.ncbi.nlm.nih.gov/pubmed/36661254 http://dx.doi.org/10.1177/23247096221150636

Ejemplares similares

Methicillin-Resistant Staphylococcus aureus Sepsis and Orbital Cellulitis Leading to a Combined Central Retinal Artery and Vein Occlusion: A Case Report
por: Damani, Devanshi Narendra, et al.
Publicado: (2023)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Jones, Peter BB, et al.
Publicado: (2010)

Leflunomide-induced and paraneoplastic ulcers in a rheumatoid arthritis patient
por: Vittori, Michael R., et al.
Publicado: (2022)

The Effect of Leflunomide on Cold and Vibratory Sensation in Patients with Rheumatoid Arthritis
por: Kim, Hyung Kuk, et al.
Publicado: (2012)

Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
por: Shashikumar, N.S., et al.
Publicado: (2010)

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
por: Hopkins, AM, et al.
Publicado: (2015)

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
por: Narváez, Javier, et al.
Publicado: (2015)

Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
por: Gualberto Cardoso, Pablo Ramon, et al.
Publicado: (2021)

Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis
por: Chen, Fang, et al.
Publicado: (2022)

Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
por: Lee, Sang-Won, et al.
Publicado: (2012)

Tripterygium Glycosides Combined with Leflunomide for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Yang, Yi-Jing, et al.
Publicado: (2020)

The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis
por: Chen, Yulan, et al.
Publicado: (2023)

Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study
por: Kellner, Herbert, et al.
Publicado: (2010)

Brain abscess in a rheumatoid arthritis patient treated with leflunomide – A case presentation and review
por: Samara, Efthymia, et al.
Publicado: (2021)

Necrotizing autoimmune myopathy
por: Babu, Sachin Suresh, et al.
Publicado: (2016)

Pediatric immune-mediated necrotizing myopathy
por: Wang, Chen-Hua, et al.
Publicado: (2023)

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis
por: Wiese, Michael D, et al.
Publicado: (2012)

Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis
por: Krishnan, Yadhu, et al.
Publicado: (2018)

Non-healing tongue ulcer in a rheumatoid arthritis patient medicated with leflunomide. An adverse drug event?
por: Kalogirou, Eleni-Marina, et al.
Publicado: (2017)

Necrotizing tracheobronchitis associated with rheumatoid arthritis
por: Kajikawa, Shigehisa, et al.
Publicado: (2016)

Immune-Mediated Necrotizing Myopathy Manifesting after Five Years of Statin Therapy
por: DeRon, Nathan G., et al.
Publicado: (2023)

Statin-Induced Immune-Mediated Necrotizing Myopathy: An Increasingly Recognized Inflammatory Myopathy
por: Stroie, Oana P, et al.
Publicado: (2020)

Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide
por: Dziedziejko, Violetta, et al.
Publicado: (2011)

Clinical outcomes of low-dose leflunomide for rheumatoid arthritis complicated with Hepatitis B virus carriage and safety observation
por: Ming-Xu, Hua, et al.
Publicado: (2015)

IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide
por: Zhong, Wei, et al.
Publicado: (2017)

Dystrophic calcinosis in a patient with overlap syndrome (scleroderma and rheumatoid arthritis) treated by leflunomide: A case report
por: Lee, Sang Yeob, et al.
Publicado: (2018)

Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis
por: Huang, Yao, et al.
Publicado: (2019)

Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial
por: Zhang, Chi, et al.
Publicado: (2019)

Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology
por: Carubbi, Francesco, et al.
Publicado: (2019)

Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Zhang, Xiaogang, et al.
Publicado: (2022)

The Efficacy and Safety of the Combination of Total Glucosides of Peony and Leflunomide for the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis
por: Feng, Zhitao, et al.
Publicado: (2016)

Monitoring of Peripheral Blood Leukocytes and Plasma Samples: A Pilot Study to Examine Treatment Response to Leflunomide in Rheumatoid Arthritis
por: Rodrigues, João F. S., et al.
Publicado: (2021)

Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
por: Behrens, Frank, et al.
Publicado: (2021)

Lack of association between CYB5A gene rs1790834 polymorphism and the response to leflunomide in women with rheumatoid arthritis
por: Łączna, Małgorzata, et al.
Publicado: (2021)

Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Qi, Weiyu, et al.
Publicado: (2021)

Immune-mediated necrotizing myopathy due to statins exposure
por: VILLA, LUISA, et al.
Publicado: (2018)

Immune-mediated necrotizing myopathy: Report of two cases
por: Chen, Bi-Hong, et al.
Publicado: (2023)

Characteristics of cardiac involvement in immune-mediated necrotizing myopathy
por: Liu, Mengyang, et al.
Publicado: (2023)

Statin-Induced Necrotizing Autoimmune Myopathy
por: Gawey, Brent, et al.
Publicado: (2020)

Statin-Induced Autoimmune Necrotizing Myopathy
por: Jayatilaka, Sahani, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p0hc5cao64208r760ikht17ujm